TRVN
  
  
      
        Trevena, Inc.
      
      
        
          TRVN
        
        
      
    
  
          TRVN
        
        
      Delisted
    TRVN was delisted on the 7th of October, 2024.
About: Trevena Inc is an American biopharmaceutical company focused on developing and commercializing novel medicines for patients affected by central nervous system, or CNS, disorders.
Employees: 23
      Price charts implemented using
      
        Lightweight Charts™